companydata.dkcompanydata.dk

CURO Diagnostics ApS: Financial statements 2023

CVR: 33960549

Source: annual report 2023, Danish Business Authority

01/01/202331/12/2023

CURO Diagnostics ApS (CVR 33960549) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 30,176 and a net result of DKK -705,735 compared with DKK -601,417 the year before. Equity in the 2023 report amounted to DKK 15,661. The solvency ratio was 0.8%.

Gross Profit
DKK 30,176
Profit/Loss
DKK -705,735
Equity
DKK 15,661
Total Assets
DKK 1,975,876
Employees
0

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2023-30 t.-706 t.16 t.0
2022--3 t.-601 t.721 t.1
2021-652 t.283 t.1.3 mio.-
2020-133 t.187 t.1 mio.0
2019-562 t.498 t.853 t.0

Official annual report

View the official annual report directly on the page with a Pro subscription.

Fetch this data via API

Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.

See the API documentation

Events in 2023

CURO Diagnostics ApS: The 2022 annual report is outJun 12, 2023

CURO Diagnostics ApS has published its annual report for 2022. Gross profit came to DKK -2,695, and the net result was DKK -601,417.

About CURO Diagnostics ApS

CURO Diagnostics ApS is a Danish company of the type Anpartsselskab based in Bagsværd, founded in 2011. The company is under bankruptcy. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named MYODYNAMIK ApS. The company's owners include MARTIN STERNDORFF HOLDING ApS, ULRIK DANNESKIOLD-SAMSØE HOLDING A/S and SENTIO HOLDINGS ApS. The company has 0 employees (2018). In 2023, the company reported a gross profit of DKK 30,176 and a net result of DKK -705,735 compared with DKK -601,417 the year before. Equity in the 2023 report amounted to DKK 15,661.

Source: annual report 2023, Danish Business Authority